MRC announces cross-council awards worth nearly £10m to tackle antibiotic resistance
Monday, 23 May 2016 09:17
Three large collaborative grants, totalling £9.5m, have been announced by the MRC as part of a cross-council initiative to tackle antimicrobial resistance (AMR).
The awards together mark one of the biggest investments into AMR since the initiative launched and will use new technology to exploit natural compounds, develop a tool to offer better and faster diagnostics and explore how the body’s own immune system can be boosted to fight infection.
AMR is a significant and growing challenge. The world is facing an increase in the number and type of bacteria resistant to antibiotics alongside stagnation in the development of new antibiotics or viable alternatives. It is clear that an interdisciplinary approach at a global level is needed to tackle the challenge if we are to save millions of lives being lost as a result of antibiotic-resistant bacteria.
The MRC has been working with the other research councils that form Research Councils UK to identify research opportunities that cross disciplines to help tackle the rise in AMR.
The latest round of awards has been funded by the MRC, Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Sciences Research Council (EPSRC) and Economic and Social Research Council (ESRC) through the AMR cross-council initiative, established in 2014 as part of a strategic and co-ordinated effort to address the growing problem head on.
A Project Summary:
Accelerating development of infection diagnostics for patient management and reduction of antibiotic misuse
Professor Christoph Wälti at the University of Leeds
Rapid diagnostic tools are urgently needed to stop the unnecessary use of antibiotics. This project will develop a new tool that can be used by doctors to detect the presence of a bacterial or viral infection quickly before antibiotics are prescribed. The test will also be able to tell which bacterial strain has caused the infection, as different strains require different treatments, and whether the particular type is commonly resistant to antibiotics. This will allow for a much more targeted use of antibiotics, reducing the number of prescriptions and increasing efficacy for patients.
International Podcasts Pertaining to Gastroenterology
Friday, 20 May 2016 14:47
The research team here at the BSG has recently recommenced updating the podcast resources page.
Regular visits will ensure that you do not miss anything.
BBSRC, MRC, AHRC, ESRC, NERC pledge £40M in new bid to tackle global challenges
Monday, 16 May 2016 09:12
Five UK Research Councils have announced the first joint interdisciplinary calls from the new £1.5Bn Global Challenges Research Fund (GCRF) unveiled by the Government in last year’s spending review.
Worth over £40M, the new calls are in non-communicable diseases, global infection and agriculture and food systems. They aim to leverage the UK’s world-class research base to help provide solutions to reduce and prevent diseases in humans and farmed animals, ensure a safe, nutritious and sustainable supply of food for a growing population and improve the life-long health of billions of people in low and middle income countries.
This funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and the Medical Research Council (MRC), with support from the Arts and Humanities Research Council (AHRC), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC) reflects the complexity of the challenges we face and the need for all disciplines to contribute to achieve international development goals.
The MRC, with support from AHRC, BBSRC, ESRC and NERC, now aims to catalyse further change to meet emerging global health challenges by making funding available for Foundation Awards in two areas, responding to aligned global strategies in:
These strategies complement the BBSRC led, and MRC supported, Foundation call in Global Agriculture and Food Systems.
Deadline for proposal outline: 16.00 (GMT+1) on 22 June 2016.
The full proposal open call will open in July 2016.
Full proposal deadline: 22 September 2016
The European Alliance for Personalised Medicine Annual Conference Report
Thursday, 12 May 2016 10:35
This was the fourth annual gathering, with speakers and attendees drawn from a wide range of stakeholder groups including patients, healthcare professionals, academics, industry representatives, politicians and legislators, the media and more. The two days featured plenary and roundtable sessions on subjects ranging from HTA, rare diseases, new methods for clinical trials, genetic mapping, Big Data and the implementation of the Luxembourg Presidency’s landmark EU Council Conclusions.
The report provides an overview of these issues.
Page 7 of 18